"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours

Por Champion, Brian R, Kodialbail, Prithvi, Illingworth, Sam, Rasiah, Nalini, Cochrane, Dan, Beadle, John, Fisher, Kerry, Brown, Alice CN
Publicado no J Immunother Cancer (2014)

Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer

Por Champion, Brian R, Rasiah, Nalini, Illingworth, Sam, Calderon, Hugo, Besneux, Matthieu, Lear, Rochelle, Plumb, Darren, Kodialbail, Prithvi, Brown, Alice
Publicado no J Immunother Cancer (2015)